Americans spend roughly $13,000 per person on healthcare each year—more than any other wealthy nation on Earth, and more than double what residents of Canada, Germany, or Australia pay for systems that routinely outperform the United States on life expectancy, infant mortality, and access to primary care, according to data published annually by the Organisation for Economic Co-operation and Development. Those numbers are not new. Policy researchers have cited them for two decades. What has changed is the political temperature around the crisis: healthcare has become the defining domestic policy fault line of 2026, and the debate between the two competing reform camps is louder, more polarized, and less productive than at any point since the Affordable Care Act passed in 2010.
I have covered healthcare policy from hospital emergency rooms in Columbus, Ohio to congressional budget hearings in Washington for fifteen years. My conclusion, after watching every iteration of this argument, is a simple one: neither the single-payer camp nor the ACA-repair camp is entirely right, and neither can succeed without borrowing from the other.
The Case Against the Status Quo
Start with what the current system reliably delivers: financial catastrophe. Medical debt is the single largest driver of personal bankruptcy filings in the United States, affecting nearly 500,000 households annually according to research published in the American Journal of Medicine. That figure holds even for insured Americans. Having a health insurance card does not guarantee protection from financial ruin—it merely changes the timeline and terms of how that ruin arrives. High-deductible plans that technically provide coverage but require families to spend $8,000 or $10,000 before meaningful insurance benefits kick in are not, in any practical sense, insurance.
The ACA extended coverage to an estimated 20 million Americans who previously had none, and its protections for people with pre-existing conditions represent a genuine policy achievement that polls consistently well across party lines. But premiums in ACA marketplace plans have continued climbing faster than wages. Deductibles have grown to the point where millions of working families hold coverage they are effectively unable to use without triggering financial stress. And the coverage gaps—particularly in states that refused Medicaid expansion, leaving millions of low-income adults in a coverage dead zone—remain wide enough to cost lives every year. The Urban Institute estimated in 2024 that uninsurance in non-expansion states contributes to approximately 20,000 preventable deaths annually.
Why Medicare for All Is Not a Simple Answer
Medicare for All has a compelling internal logic that cannot be dismissed by anyone who has looked seriously at comparative health systems data. A single insurer with the bargaining power of the federal government can negotiate drug prices to fractions of current levels, eliminate the enormous administrative overhead that consumes roughly 30 cents of every healthcare dollar in the current system, and create a universal risk pool that protects everyone regardless of employment status, geography, or employer generosity. Every other large democracy has arrived at some version of this arrangement and achieved better health outcomes at lower cost. That is not an ideological claim. It is a documented empirical pattern across thirty-plus OECD member nations.
The transition problem, however, is not theoretical. Moving 160 million Americans off employer-sponsored insurance plans within a four-year implementation window would restructure approximately one-sixth of the U.S. economy, eliminate hundreds of thousands of insurance industry jobs concentrated in cities like Hartford, Indianapolis, and Minneapolis, and require a new tax structure that the Congressional Budget Office has assessed in the range of $32 to $38 trillion over ten years. The politics of that ask—in a country where a consistent majority of insured adults report satisfaction with their current plan, even when they simultaneously report dissatisfaction with the healthcare system overall—are brutal even under the most favorable electoral conditions imaginable.
The Pragmatic Path Forward
The strongest case is for a genuine public option: a government-administered health plan that competes directly with private insurance on ACA marketplaces, is made available to employers of any size who choose to offer it, and operates with Medicare's pricing leverage to discipline what providers and pharmaceutical companies can charge. That structure exists in varying forms in Australia, the Netherlands, Germany, and Switzerland. It preserves private insurance for people who want it and preserves employer benefits for those whose plans genuinely work. It creates a competitive alternative that disciplines premiums through market pressure rather than mandates, and it builds over time toward the administrative simplification and bargaining power that single-payer advocates correctly identify as the system's central efficiencies.
The political prerequisites are real and not currently in place. A robust public option requires a Congress willing to take on pharmaceutical and insurance industry lobbying, a president willing to spend substantial political capital, and an industry that has historically spent billions of dollars to prevent exactly this outcome from becoming law. The public option proposals that passed the House in 2021 died in the Senate, and the current legislative environment is considerably less favorable to ambitious healthcare legislation.
The Cost of Waiting
But the math of American healthcare is moving faster than the politics. Premium growth, medical debt accumulation, pharmaceutical pricing, and workforce shortages in primary care are all compounding in ways that reduce the number of viable options available to future policymakers. The rural healthcare crisis—dozens of hospital closures in states like West Virginia, Kansas, and Mississippi have left entire counties without inpatient services—is already a crisis that purely market-based solutions have shown no sign of resolving.
At some point, the system will force a decision. The only question is whether that decision is made deliberately, on terms that preserve what works while fixing what demonstrably does not, or reactively, in a crisis environment that leaves policymakers with fewer options, more political pressure, and less time to think clearly. Waiting is not a healthcare policy. It is a bet that a system that has failed to correct itself for thirty years will somehow self-correct before the consequences become unavoidable. History, and the lived experience of forty million uninsured and underinsured Americans, suggests it will not.